property,propLabel,axiomValue,axValLabel,count
obo:RO_0002573,has modifier,obo:MONDO_0021136,rare,12928
obo:RO_0002573,has modifier,obo:MONDO_0021152,inherited,8971
obo:RO_0004026,disease has location,obo:UBERON_0001016,nervous system,6457
obo:RO_0004024,disease disrupts,obo:GO_0032502,developmental process,5453
obo:RO_0004024,disease causes disruption of,obo:GO_0032502,developmental process,5453
obo:RO_0004024,disease disrupts,obo:GO_0008283,cell population proliferation,4649
obo:RO_0004024,disease disrupts,obo:GO_0008283,cell proliferation,4649
obo:RO_0004024,disease causes disruption of,obo:GO_0008283,cell population proliferation,4649
obo:RO_0004024,disease causes disruption of,obo:GO_0008283,cell proliferation,4649
obo:RO_0002573,has modifier,obo:MONDO_0021140,congenital,4419
obo:RO_0004021,disease caused by disruption of,obo:GO_0048598,embryonic morphogenesis,4258
obo:RO_0004021,disease has basis in disruption of,obo:GO_0048598,embryonic morphogenesis,4258
obo:RO_0002573,has modifier,obo:MONDO_0021127,has a syndromic presentation,4118
obo:RO_0004026,disease has location,obo:UBERON_0001017,central nervous system,3769
obo:RO_0004026,disease has location,obo:UBERON_0007811,craniocervical region,3714
obo:RO_0004026,disease has location,obo:UBERON_0000033,head,3528
obo:RO_0004026,disease has location,obo:UBERON_0002204,musculoskeletal system,3472
obo:RO_0004026,disease has location,obo:UBERON_0000955,brain,3053
obo:RO_0004026,disease has location,obo:UBERON_0002384,connective tissue,2842
obo:RO_0004026,disease has location,obo:UBERON_0001456,face,2686
obo:RO_0004026,disease has location,obo:UBERON_0002104,visual system,2538
obo:RO_0004026,disease has location,obo:UBERON_0004088,orbital region,2515
obo:RO_0004026,disease has location,obo:UBERON_0000019,camera-type eye,2481
obo:RO_0004026,disease has location,obo:UBERON_0010230,eyeball of camera-type eye,2481
obo:RO_0004026,disease has location,obo:UBERON_0001434,skeletal system,2286
obo:RO_0002573,has modifier,obo:PATO_0002097,"neoplastic, malignant",2190
obo:RO_0004026,disease has location,obo:UBERON_0002416,integumental system,2118
obo:RO_0004021,disease caused by disruption of,obo:GO_0008152,metabolic process,2009
obo:RO_0004021,disease has basis in disruption of,obo:GO_0008152,metabolic process,2009
obo:RO_0004024,disease disrupts,obo:MF_0000020,mental process,1946
obo:RO_0004024,disease causes disruption of,obo:MF_0000020,mental process,1946
obo:RO_0004026,disease has location,obo:UBERON_0000949,endocrine system,1914
obo:RO_0004026,disease has location,obo:UBERON_0002481,bone tissue,1895
obo:RO_0004026,disease has location,obo:UBERON_0001007,digestive system,1877
obo:RO_0004026,disease has location,obo:UBERON_0004535,cardiovascular system,1813
obo:RO_0004026,disease has location,obo:UBERON_0000014,zone of skin,1695
obo:RO_0004026,disease has location,obo:UBERON_0002417,abdominal segment of trunk,1606
obo:RO_0004026,disease has location,obo:UBERON_0000915,thoracic segment of trunk,1573
obo:RO_0004026,disease has location,obo:UBERON_0004122,genitourinary system,1537
obo:RO_0004026,disease has location,obo:UBERON_0002405,immune system,1527
obo:RO_0004021,disease caused by disruption of,obo:MF_0000020,mental process,1493
obo:RO_0004021,disease has basis in disruption of,obo:MF_0000020,mental process,1493
obo:RO_0004026,disease has location,obo:UBERON_0000990,reproductive system,1477
obo:RO_0004030,disease arises from structure,obo:CL_0000066,epithelial cell,1452
obo:RO_0004026,disease has location,obo:UBERON_0000010,peripheral nervous system,1344
obo:RO_0004021,disease caused by disruption of,obo:GO_0060348,bone development,1318
obo:RO_0004021,disease has basis in disruption of,obo:GO_0060348,bone development,1318
obo:RO_0004026,disease has location,obo:UBERON_0002390,hematopoietic system,1265
obo:RO_0004026,disease has location,obo:UBERON_0001008,renal system,1187
obo:RO_0004024,disease disrupts,obo:GO_0006954,inflammatory response,1159
obo:RO_0004024,disease causes disruption of,obo:GO_0006954,inflammatory response,1159
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000061,anatomical structure,1159
obo:RO_0004026,disease has location,obo:UBERON_0007798,vascular system,1031
obo:RO_0004026,disease has location,obo:UBERON_0001630,muscle organ,1027
obo:RO_0004026,disease has location,obo:UBERON_0002049,vasculature,1024
obo:RO_0004026,disease has location,obo:UBERON_0002385,muscle tissue,1013
obo:RO_0004026,disease has location,obo:CL_0000066,epithelial cell,1009
obo:RO_0004026,disease has location,obo:UBERON_0002113,kidney,992
obo:RO_0004026,disease has location,obo:UBERON_0000474,female reproductive system,917
obo:RO_0002573,has modifier,obo:HP_0000007,Autosomal recessive inheritance,857
obo:RO_0002573,has modifier,obo:MONDO_0021128,has an isolated presentation,837
obo:RO_0004029,disease has feature,obo:HP_0001250,Seizures,834
obo:RO_0004026,disease has location,obo:UBERON_0001004,respiratory system,811
obo:RO_0004026,disease has location,obo:UBERON_0000948,heart,777
obo:RO_0004024,disease disrupts,obo:GO_0050905,neuromuscular process,766
obo:RO_0004024,disease causes disruption of,obo:GO_0050905,neuromuscular process,766
mondo:disease_has_major_feature,disease has major feature,obo:HP_0007313,Cerebral degeneration,725
mondo:disease_has_major_feature,disease has major feature,obo:HP_0100022,Abnormality of movement,704
obo:RO_0004024,disease disrupts,obo:GO_0001503,ossification,700
obo:RO_0004024,disease causes disruption of,obo:GO_0001503,ossification,700
obo:RO_0002573,has modifier,obo:PATO_0002096,"neoplastic, non-malignant",664
obo:RO_0004026,disease has location,obo:UBERON_0000160,intestine,643
obo:RO_0004026,disease has location,obo:UBERON_0000966,retina,617
obo:RO_0002573,has modifier,obo:HP_0000006,Autosomal dominant inheritance,616
mondo:disease_has_major_feature,disease has major feature,obo:HP_0040064,Abnormality of limbs,606
obo:RO_0004026,disease has location,obo:UBERON_0016490,auditory system,598
obo:RO_0004024,disease disrupts,obo:GO_0007600,sensory perception,584
obo:RO_0004024,disease causes disruption of,obo:GO_0007600,sensory perception,584
obo:RO_0004026,disease has location,obo:UBERON_0002368,endocrine gland,568
obo:RO_0004026,disease has location,obo:UBERON_0035639,ocular adnexa,542
obo:RO_0004026,disease has location,obo:UBERON_0000991,gonad,528
obo:RO_0004026,disease has location,obo:UBERON_0001798,vitreous body,519
obo:RO_0004026,disease has location,obo:UBERON_0000079,male reproductive system,496
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0020022,central nervous system malformation,495
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0099080,supramolecular complex,489
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0043292,contractile fiber,488
obo:RO_0004029,disease has feature,obo:HP_0003198,Myopathy,488
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0005027,epilepsy,483
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0043227,membrane-bounded organelle,480
obo:RO_0004024,disease disrupts,obo:GO_0007605,sensory perception of sound,474
obo:RO_0004024,disease causes disruption of,obo:GO_0007605,sensory perception of sound,474
obo:RO_0004029,disease has feature,obo:MONDO_0005066,metabolic disease,467
obo:RO_0004026,disease has location,obo:UBERON_0001134,skeletal muscle tissue,446
obo:RO_0004029,disease has feature,obo:HP_0000556,Retinal dystrophy,445
obo:RO_0004025,disease causes dysfunction of,obo:UBERON_0000966,retina,445
obo:RO_0004021,disease caused by disruption of,obo:GO_0002524,hypersensitivity,444
obo:RO_0004021,disease has basis in disruption of,obo:GO_0002524,hypersensitivity,444
obo:RO_0004026,disease has location,obo:GO_0030849,autosome,442
obo:RO_0004029,disease has feature,obo:HP_0002027,Abdominal pain,439
obo:RO_0004024,disease disrupts,obo:MF_0000008,cognitive process,437
obo:RO_0004024,disease causes disruption of,obo:MF_0000008,cognitive process,437
obo:RO_0004026,disease has location,obo:UBERON_0000021,cutaneous appendage,430
obo:RO_0004030,disease arises from structure,obo:CL_0000988,hematopoietic cell,405
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_2,Bacteria,400
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000726,Dementia,394
obo:RO_0004026,disease has location,obo:UBERON_0001558,lower respiratory tract,392
obo:RO_0004021,disease caused by disruption of,obo:GO_0006091,generation of precursor metabolites and energy,384
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006091,generation of precursor metabolites and energy,384
obo:RO_0004021,disease caused by disruption of,obo:GO_0005975,carbohydrate metabolic process,380
obo:RO_0004021,disease has basis in disruption of,obo:GO_0005975,carbohydrate metabolic process,380
obo:RO_0004026,disease has location,obo:UBERON_0003134,female reproductive organ,376
obo:RO_0002573,has modifier,obo:HP_0010985,Gonosomal inheritance,375
obo:RO_0002573,has modifier,obo:HP_0001417,X-linked inheritance,371
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0005070,neoplasm (disease),360
obo:RO_0004029,disease has feature,obo:HP_0000789,Infertility,359
obo:RO_0004024,disease disrupts,obo:GO_0006082,organic acid metabolic process,355
obo:RO_0004024,disease causes disruption of,obo:GO_0006082,organic acid metabolic process,355
obo:RO_0004026,disease has location,obo:UBERON_0002423,hepatobiliary system,351
obo:RO_0004024,disease disrupts,obo:GO_0043010,camera-type eye development,348
obo:RO_0004024,disease causes disruption of,obo:GO_0043010,camera-type eye development,348
obo:RO_0004026,disease has location,obo:UBERON_0001003,skin epidermis,337
obo:RO_0004026,disease has location,obo:UBERON_0001133,cardiac muscle tissue,335
obo:RO_0004026,disease has location,obo:UBERON_0001711,eyelid,334
obo:RO_0004026,disease has location,obo:UBERON_0002048,lung,332
obo:RO_0004022,disease arises from feature,obo:HP_0002960,Autoimmunity,331
obo:RO_0004022,disease has basis in feature,obo:HP_0002960,Autoimmunity,331
obo:RO_0002573,has modifier,obo:MONDO_0022201,has treatment by surgery,331
obo:RO_0004021,disease caused by disruption of,obo:GO_0006082,organic acid metabolic process,330
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006082,organic acid metabolic process,330
obo:RO_0004030,disease arises from structure,obo:CL_0002494,cardiocyte,319
obo:RO_0004026,disease has location,obo:UBERON_0000165,mouth,311
obo:RO_0004029,disease has feature,obo:MONDO_0001517,dysentery,305
obo:RO_0004030,disease arises from structure,obo:CL_0008019,mesenchymal cell,302
obo:RO_0002573,has modifier,obo:HP_0011463,Childhood onset,297
obo:RO_0004026,disease has location,obo:CL_0000738,leukocyte,292
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001317,Abnormal cerebellum morphology,290
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001317,Abnormality of the cerebellum,290
obo:RO_0004021,disease caused by disruption of,obo:GO_0034101,erythrocyte homeostasis,289
obo:RO_0004021,disease has basis in disruption of,obo:GO_0034101,erythrocyte homeostasis,289
obo:RO_0004024,disease disrupts,obo:GO_0006629,lipid metabolic process,287
obo:RO_0004024,disease causes disruption of,obo:GO_0006629,lipid metabolic process,287
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005739,mitochondrion,286
obo:RO_0004021,disease caused by disruption of,obo:GO_0072358,cardiovascular system development,285
obo:RO_0004021,disease has basis in disruption of,obo:GO_0072358,cardiovascular system development,285
obo:RO_0004021,disease caused by disruption of,obo:GO_0009117,nucleotide metabolic process,284
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009117,nucleotide metabolic process,284
obo:RO_0004026,disease has location,obo:UBERON_0002037,cerebellum,283
obo:RO_0002573,has modifier,obo:MONDO_0021141,acquired,280
obo:RO_0004024,disease disrupts,obo:GO_0009117,nucleotide metabolic process,279
obo:RO_0004024,disease causes disruption of,obo:GO_0009117,nucleotide metabolic process,279
obo:RO_0004026,disease has location,obo:UBERON_0000065,respiratory tract,274
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_10239,Viruses,266
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_10239,virus,266
obo:RO_0004026,disease has location,obo:UBERON_0002107,liver,265
obo:RO_0004026,disease has location,obo:UBERON_0000965,lens of camera-type eye,264
obo:RO_0004026,disease has location,obo:UBERON_0001637,artery,261
obo:RO_0004021,disease caused by disruption of,obo:GO_0002250,adaptive immune response,258
obo:RO_0004021,disease has basis in disruption of,obo:GO_0002250,adaptive immune response,258
obo:RO_0004030,disease arises from structure,obo:CL_0000586,germ cell,253
obo:RO_0004029,disease has feature,obo:HP_0001251,Ataxia,252
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0002037,cerebellum,251
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001251,Ataxia,249
obo:RO_0004024,disease disrupts,obo:GO_0007596,blood coagulation,241
obo:RO_0004024,disease causes disruption of,obo:GO_0007596,blood coagulation,241
obo:RO_0004021,disease caused by disruption of,obo:GO_0014032,neural crest cell development,240
obo:RO_0004021,disease has basis in disruption of,obo:GO_0014032,neural crest cell development,240
obo:RO_0004026,disease has location,obo:UBERON_0001264,pancreas,238
obo:RO_0004026,disease has location,obo:UBERON_0000995,uterus,235
obo:RO_0004026,disease has location,obo:UBERON_0000992,ovary,232
obo:RO_0004026,disease has location,obo:UBERON_0000992,female gonad,232
obo:RO_0004021,disease caused by disruption of,obo:GO_0007507,heart development,230
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007507,heart development,230
obo:RO_0004026,disease has location,obo:UBERON_0000059,large intestine,227
obo:RO_0004030,disease arises from structure,obo:UBERON_0034705,developing neuroepithelium,224
obo:RO_0004026,disease has location,obo:UBERON_0036302,vasculature of central nervous system plus retina,224
obo:RO_0002573,has modifier,obo:PATO_0000389,acute,221
obo:RO_0004024,disease disrupts,obo:GO_0006119,oxidative phosphorylation,216
obo:RO_0004024,disease causes disruption of,obo:GO_0006119,oxidative phosphorylation,216
obo:RO_0002573,has modifier,obo:PATO_0001863,chronic,216
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0032991,protein-containing complex,214
obo:RO_0004021,disease caused by disruption of,obo:GO_0045087,innate immune response,206
obo:RO_0004021,disease has basis in disruption of,obo:GO_0045087,innate immune response,206
mondo:disease_has_major_feature,disease has major feature,obo:HP_0007754,Macular dystrophy,206
obo:RO_0004026,disease has location,obo:UBERON_0002465,lymphoid system,205
obo:RO_0004024,disease disrupts,obo:GO_0003824,catalytic activity,204
obo:RO_0004024,disease causes disruption of,obo:GO_0003824,catalytic activity,204
obo:RO_0004026,disease has location,obo:UBERON_0000074,renal glomerulus,204
obo:RO_0004026,disease has location,obo:UBERON_0034713,cranial neuron projection bundle,204
obo:RO_0002573,has modifier,obo:MONDO_0045036,primary infectious,203
mondo:disease_has_basis_in_development_of,disease_has_basis_in_development_of,obo:UBERON_0000924,ectoderm,201
obo:RO_0004021,disease caused by disruption of,obo:GO_0002376,immune system process,196
obo:RO_0004021,disease has basis in disruption of,obo:GO_0002376,immune system process,196
obo:RO_0004026,disease has location,obo:UBERON_0000310,breast,196
obo:RO_0004026,disease has location,obo:UBERON_0002067,dermis,196
obo:RO_0004021,disease caused by disruption of,obo:GO_0006520,cellular amino acid metabolic process,193
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006520,cellular amino acid metabolic process,193
obo:RO_0004021,disease caused by disruption of,obo:GO_0070085,glycosylation,193
obo:RO_0004021,disease has basis in disruption of,obo:GO_0070085,glycosylation,193
obo:RO_0004026,disease has location,obo:UBERON_0000964,cornea,193
obo:RO_0004026,disease has location,obo:UBERON_0004765,skeletal element,192
obo:RO_0004026,disease has location,obo:UBERON_0006558,lymphatic part of lymphoid system,190
obo:RO_0004026,disease has location,obo:UBERON_0003672,dentition,189
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000014,zone of skin,186
obo:RO_0004026,disease has location,obo:UBERON_0001981,blood vessel,182
obo:RO_0004026,disease has location,obo:UBERON_0002371,bone marrow,180
obo:RO_0004030,disease arises from structure,obo:UBERON_0004638,blood vessel endothelium,178
obo:RO_0004026,disease has location,obo:UBERON_0005409,alimentary part of gastrointestinal system,171
obo:RO_0004026,disease has location,obo:UBERON_0011932,pilosebaceous unit,171
obo:RO_0004026,disease has location,obo:UBERON_0012652,colorectum,171
obo:RO_0004026,disease has location,obo:UBERON_0003129,skull,169
obo:RO_0004026,disease has location,obo:CL_0000236,B cell,167
obo:RO_0004022,disease arises from feature,obo:MONDO_0005550,infectious disease,167
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005550,infectious disease,167
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0009773,renal tubule,167
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005764,lysosome,165
obo:RO_0004026,disease has location,obo:UBERON_0000016,endocrine pancreas,165
obo:RO_0004029,disease has feature,obo:HP_0004348,Abnormality of bone mineral density,161
obo:RO_0004024,disease disrupts,obo:GO_0005215,transporter activity,160
obo:RO_0004024,disease causes disruption of,obo:GO_0005215,transporter activity,160
obo:RO_0004024,disease disrupts,obo:GO_0033059,cellular pigmentation,159
obo:RO_0004024,disease causes disruption of,obo:GO_0033059,cellular pigmentation,159
obo:RO_0004026,disease has location,obo:UBERON_0002369,adrenal gland,159
obo:RO_0004030,disease arises from structure,obo:CL_0000076,squamous epithelial cell,158
obo:RO_0004026,disease has location,obo:UBERON_0002240,spinal cord,158
obo:RO_0004026,disease has location,obo:UBERON_0001173,biliary tree,157
obo:RO_0004026,disease has location,obo:UBERON_0002046,thyroid gland,157
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005929,cilium,156
obo:RO_0004026,disease has location,obo:UBERON_0002027,stratum corneum of epidermis,156
obo:RO_0004026,disease has location,obo:UBERON_0009773,renal tubule,153
obo:RO_0004026,disease has location,obo:UBERON_0003135,male reproductive organ,150
obo:RO_0004024,disease disrupts,obo:GO_0006006,glucose metabolic process,147
obo:RO_0004024,disease causes disruption of,obo:GO_0006006,glucose metabolic process,147
obo:RO_0004026,disease has location,obo:UBERON_0001091,calcareous tooth,143
obo:RO_0004026,disease has location,obo:UBERON_0002530,gland,143
obo:RO_0004029,disease has feature,obo:MONDO_0005027,epilepsy,142
obo:RO_0004021,disease caused by disruption of,obo:GO_0005216,ion channel activity,141
obo:RO_0004021,disease has basis in disruption of,obo:GO_0005216,ion channel activity,141
obo:RO_0004026,disease has location,obo:UBERON_0001557,upper respiratory tract,139
obo:RO_0004024,disease disrupts,obo:GO_0031424,keratinization,138
obo:RO_0004024,disease causes disruption of,obo:GO_0031424,keratinization,138
obo:RO_0004026,disease has location,obo:CL_0000100,motor neuron,134
obo:RO_0004026,disease has location,obo:UBERON_0010133,neuroendocrine gland,133
obo:RO_0004030,disease arises from structure,obo:CL_0000125,glial cell,132
obo:RO_0004021,disease caused by disruption of,obo:GO_0007548,sex differentiation,132
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007548,sex differentiation,132
obo:RO_0004026,disease has location,obo:UBERON_0001768,uvea,132
obo:RO_0004026,disease has location,obo:UBERON_0001811,conjunctiva,130
obo:RO_0004030,disease arises from structure,obo:CL_0000148,melanocyte,129
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001017,central nervous system,129
obo:RO_0004026,disease has location,obo:UBERON_0002074,hair shaft,129
obo:RO_0004026,disease has location,obo:UBERON_0002394,bile duct,129
obo:RO_0004022,disease arises from feature,obo:MONDO_0005108,viral infectious disease,128
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005108,viral infectious disease,128
mondo:disease_has_major_feature,disease has major feature,obo:HP_0003429,CNS hypomyelination,126
obo:RO_0004026,disease has location,obo:UBERON_0002101,limb,126
obo:RO_0004029,disease has feature,obo:HP_0012735,Cough,124
obo:RO_0004026,disease has location,obo:UBERON_0001032,sensory system,123
obo:RO_0004026,disease has location,obo:UBERON_0002203,vasculature of eye,123
obo:RO_0004029,disease has feature,obo:HP_0002321,Vertigo,122
obo:RO_0002573,has modifier,obo:MONDO_0024495,"tumor grade 1 or 2, general grading system",121
obo:RO_0004026,disease has location,obo:UBERON_0001690,ear,121
obo:RO_0004022,disease arises from feature,obo:MONDO_0005559,neurodegenerative disease,120
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005559,neurodegenerative disease,120
obo:RO_0002573,has modifier,obo:MONDO_0024497,"tumor grade 3 or 4, general grading system",119
obo:RO_0004029,disease has feature,obo:MONDO_0002280,anemia (disease),118
obo:RO_0004029,disease has feature,obo:HP_0000496,Abnormality of eye movement,115
obo:RO_0004029,disease has feature,obo:HP_0000508,Ptosis,115
obo:RO_0004021,disease caused by disruption of,obo:GO_0009100,glycoprotein metabolic process,114
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009100,glycoprotein metabolic process,114
obo:RO_0004026,disease has location,obo:UBERON_0001155,colon,114
obo:RO_0004022,disease arises from feature,obo:HP_0000822,Hypertension,113
obo:RO_0004022,disease has basis in feature,obo:HP_0000822,Hypertension,113
obo:RO_0004029,disease has feature,obo:HP_0001257,Spasticity,113
obo:RO_0004029,disease has feature,obo:HP_0010550,Paraplegia,113
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000233,platelet,112
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001156,Brachydactyly,112
obo:RO_0004029,disease has feature,obo:HP_0001156,Brachydactyly,112
obo:RO_0004026,disease has location,obo:UBERON_0004573,systemic artery,112
obo:RO_0004030,disease arises from structure,obo:UBERON_0012429,hematopoietic tissue,111
obo:RO_0004024,disease disrupts,obo:GO_0003015,heart process,110
obo:RO_0004024,disease causes disruption of,obo:GO_0003015,heart process,110
obo:RO_0004026,disease has location,obo:UBERON_0000945,stomach,109
obo:RO_0004026,disease has location,obo:UBERON_0000007,pituitary gland,108
mondo:disease_causes_feature,disease causes feature,obo:HP_0003074,Hyperglycemia,107
obo:RO_0004029,disease has feature,obo:HP_0004322,Short stature,107
obo:RO_0004026,disease has location,obo:UBERON_0001555,digestive tract,106
obo:RO_0004021,disease caused by disruption of,obo:GO_0016068,type I hypersensitivity,104
obo:RO_0004021,disease has basis in disruption of,obo:GO_0016068,type I hypersensitivity,104
obo:RO_0004026,disease has location,obo:UBERON_0001255,urinary bladder,104
obo:RO_0004026,disease has location,obo:UBERON_0002108,small intestine,104
obo:RO_0004026,disease has location,obo:UBERON_0000982,skeletal joint,103
obo:RO_0009501,realized in response to,obo:ECTO_0000231,exposure to chemical entity,101
obo:RO_0004021,disease caused by disruption of,obo:GO_0005183,gonadotropin hormone-releasing hormone activity,101
obo:RO_0004021,disease has basis in disruption of,obo:GO_0005183,gonadotropin hormone-releasing hormone activity,101
obo:RO_0004029,disease has feature,obo:HP_0000486,Strabismus,101
obo:RO_0004030,disease arises from structure,obo:CL_0000236,B cell,100
obo:RO_0004021,disease caused by disruption of,obo:GO_0006954,inflammatory response,100
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006954,inflammatory response,100
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0061702,inflammasome complex,100
obo:RO_0004022,disease arises from feature,obo:MONDO_0024237,inherited neurodegenerative disorder,99
obo:RO_0004022,disease has basis in feature,obo:MONDO_0024237,inherited neurodegenerative disorder,99
obo:RO_0004030,disease arises from structure,obo:CL_0000187,muscle cell,98
obo:RO_0004029,disease has feature,obo:HP_0002013,Vomiting,98
obo:RO_0004029,disease has feature,obo:MONDO_0005129,cataract (disease),97
obo:RO_0004026,disease has location,obo:UBERON_0010743,meningeal cluster,97
obo:RO_0002573,has modifier,obo:HP_0003593,Infantile onset,96
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_4751,Fungi,95
obo:RO_0004026,disease has location,obo:UBERON_0001750,lacrimal apparatus,95
obo:RO_0004026,disease has location,obo:UBERON_0002257,ventral horn of spinal cord,95
obo:RO_0004025,disease causes dysfunction of,obo:UBERON_0002521,elastic tissue,95
obo:RO_0004030,disease arises from structure,obo:CL_0000192,smooth muscle cell,94
obo:RO_0004024,disease disrupts,obo:GO_0046849,bone remodeling,94
obo:RO_0004024,disease causes disruption of,obo:GO_0046849,bone remodeling,94
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000501,Glaucoma,94
obo:RO_0004030,disease arises from structure,obo:CL_0000071,blood vessel endothelial cell,93
obo:RO_0004029,disease has feature,obo:HP_0001513,Obesity,93
obo:RO_0004021,disease caused by disruption of,obo:GO_0007565,female pregnancy,89
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007565,female pregnancy,89
obo:RO_0004024,disease disrupts,obo:GO_0016042,lipid catabolic process,89
obo:RO_0004024,disease causes disruption of,obo:GO_0016042,lipid catabolic process,89
obo:RO_0004021,disease caused by disruption of,obo:GO_0019915,lipid storage,89
obo:RO_0004021,disease has basis in disruption of,obo:GO_0019915,lipid storage,89
obo:RO_0004026,disease has location,obo:UBERON_0009097,gravid organism,89
obo:RO_0004026,disease has location,obo:UBERON_0001132,parathyroid gland,87
obo:RO_0004026,disease has location,obo:CL_0000057,fibroblast,86
obo:RO_0004030,disease arises from structure,obo:CL_0000057,fibroblast,86
obo:RO_0004024,disease disrupts,obo:GO_0007165,signal transduction,86
obo:RO_0004024,disease causes disruption of,obo:GO_0007165,signal transduction,86
obo:RO_0004026,disease has location,obo:UBERON_0000004,nose,86
obo:RO_0004026,disease has location,obo:UBERON_0000002,uterine cervix,85
obo:RO_0004026,disease has location,obo:UBERON_0001013,adipose tissue,83
obo:RO_0004026,disease has location,obo:UBERON_0002517,basicranium,83
obo:RO_0004026,disease has location,obo:UBERON_0004908,upper digestive tract,83
obo:RO_0004029,disease has feature,obo:HP_0008066,Abnormal blistering of the skin,82
obo:RO_0004026,disease has location,obo:UBERON_0008998,vasculature of brain,82
obo:RO_0004021,disease caused by disruption of,obo:GO_0006493,protein O-linked glycosylation,81
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006493,protein O-linked glycosylation,81
obo:RO_0004029,disease has feature,obo:HP_0030828,Wheezing,81
obo:BFO_0000054,realized in,obo:NCIT_C19085,Sexual Transmission,81
obo:RO_0004026,disease has location,obo:UBERON_0001043,esophagus,81
obo:RO_0004026,disease has location,obo:UBERON_0001052,rectum,81
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000953,Hyperpigmentation of the skin,80
obo:RO_0002573,has modifier,obo:HP_0003581,Adult onset,80
obo:RO_0004029,disease has feature,obo:HP_0001824,Weight loss,79
obo:RO_0004026,disease has location,obo:UBERON_0000473,testis,79
obo:RO_0004026,disease has location,obo:UBERON_0001897,dorsal plus ventral thalamus,79
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000955,brain,78
obo:RO_0004026,disease has location,obo:UBERON_0005090,muscle structure,78
obo:RO_0004021,disease caused by disruption of,obo:GO_0006281,DNA repair,76
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006281,DNA repair,76
obo:RO_0004024,disease disrupts,obo:GO_0007601,visual perception,76
obo:RO_0004024,disease causes disruption of,obo:GO_0007601,visual perception,76
obo:RO_0004030,disease arises from structure,obo:CL_0000785,mature B cell,75
obo:RO_0004021,disease caused by disruption of,obo:GO_0060235,lens induction in camera-type eye,75
obo:RO_0004021,disease has basis in disruption of,obo:GO_0060235,lens induction in camera-type eye,75
obo:RO_0004029,disease has feature,obo:HP_0000107,Renal cyst,75
obo:RO_0004029,disease has feature,obo:HP_0011001,Increased bone mineral density,74
obo:RO_0004026,disease has location,obo:UBERON_0000997,mammalian vulva,74
obo:RO_0004026,disease has location,obo:UBERON_0000946,cardial valve,73
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002049,vasculature,73
obo:RO_0004029,disease has feature,obo:HP_0002829,Arthralgia,72
obo:RO_0002573,has modifier,obo:PATO_0001673,cystic,72
obo:RO_0004026,disease has location,obo:UBERON_0001474,bone element,72
obo:RO_0004026,disease has location,obo:UBERON_0000167,oral cavity,71
obo:RO_0004026,disease has location,obo:CL_0000232,erythrocyte,70
obo:RO_0004029,disease has feature,obo:HP_0001548,Overgrowth,69
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000234,phagocyte,68
obo:RO_0004030,disease arises from structure,obo:CL_0002576,perineural cell,68
obo:RO_0004024,disease disrupts,obo:GO_0006909,phagocytosis,68
obo:RO_0004024,disease causes disruption of,obo:GO_0006909,phagocytosis,68
obo:RO_0004029,disease has feature,obo:HP_0001324,Muscle weakness,68
obo:RO_0004029,disease has feature,obo:HP_0002315,Headache,68
obo:RO_0004021,disease caused by disruption of,obo:GO_0008202,steroid metabolic process,67
obo:RO_0004021,disease has basis in disruption of,obo:GO_0008202,steroid metabolic process,67
obo:RO_0004026,disease has location,obo:UBERON_0001820,sweat gland,67
obo:RO_0002573,has modifier,obo:SO_1000029,chromosomal_deletion,66
obo:RO_0004026,disease has location,obo:UBERON_0002367,prostate gland,66
obo:RO_0004026,disease has location,obo:UBERON_0010011,collection of basal ganglia,64
obo:RO_0004029,disease has feature,obo:HP_0002503,Spinocerebellar tract degeneration,63
obo:RO_0004029,disease has feature,obo:MONDO_0100035,structural epilepsy,63
obo:RO_0004029,disease has feature,obo:HP_0001903,Anemia,62
obo:RO_0004029,disease has feature,obo:HP_0004349,Reduced bone mineral density,62
obo:RO_0002573,has modifier,obo:MONDO_0024493,"tumor grade 3, general grading system",62
obo:RO_0002573,has modifier,obo:PATO_0002132,"neoplastic, non-invasive",62
obo:RO_0004026,disease has location,obo:UBERON_0001042,chordate pharynx,62
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1763,Mycobacterium,61
obo:RO_0004026,disease has location,obo:UBERON_0001044,saliva-secreting gland,60
obo:RO_0004024,disease disrupts,obo:GO_0007568,aging,59
obo:RO_0004024,disease causes disruption of,obo:GO_0007568,aging,59
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000252,Microcephaly,59
obo:RO_0004029,disease has feature,obo:HP_0000528,Anophthalmia,59
obo:RO_0004029,disease has feature,obo:HP_0000568,Microphthalmia,59
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001010,Hypopigmentation of the skin,59
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001669,Transposition of the great arteries,59
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001710,Conotruncal defect,59
obo:RO_0004030,disease arises from structure,obo:UBERON_0001304,germinal epithelium of ovary,59
obo:RO_0004026,disease has location,obo:UBERON_0001737,larynx,59
obo:RO_0004026,disease has location,obo:UBERON_0001893,telencephalon,59
obo:RO_0004020,disease has basis in dysfunction of,obo:CHEBI_35143,hemoglobin,58
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001339,Lissencephaly,58
obo:RO_0004026,disease has location,obo:UBERON_0001825,paranasal sinus,58
obo:RO_0004026,disease has location,obo:UBERON_0002199,integument,58
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0045202,synapse,57
obo:RO_0004026,disease has location,obo:UBERON_0002349,myocardium,57
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0031594,neuromuscular junction,56
obo:RO_0004022,disease arises from feature,obo:HP_0000044,Hypogonadotrophic hypogonadism,56
obo:RO_0004022,disease has basis in feature,obo:HP_0000044,Hypogonadotrophic hypogonadism,56
obo:RO_0004026,disease has location,obo:UBERON_0002097,skin of body,56
obo:RO_0004026,disease has location,obo:UBERON_0011156,facial skeleton,56
obo:RO_0004021,disease caused by disruption of,obo:GO_0005777,peroxisome,55
obo:RO_0004021,disease has basis in disruption of,obo:GO_0005777,peroxisome,55
obo:RO_0004021,disease caused by disruption of,obo:GO_0006790,sulfur compound metabolic process,55
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006790,sulfur compound metabolic process,55
obo:RO_0004029,disease has feature,obo:HP_0002105,Hemoptysis,55
mondo:disease_has_major_feature,disease has major feature,obo:HP_0007773,Vitreoretinopathy,55
obo:RO_0004029,disease has feature,obo:HP_0010442,Polydactyly,55
obo:RO_0004026,disease has location,obo:UBERON_0001135,smooth muscle tissue,55
obo:RO_0004026,disease has location,obo:UBERON_0001898,hypothalamus,55
obo:RO_0004029,disease has feature,obo:MONDO_0002516,digestive system cancer,54
obo:RO_0004029,disease has feature,obo:MONDO_0005093,skin disease,54
obo:RO_0004026,disease has location,obo:UBERON_0000020,sense organ,54
obo:RO_0004026,disease has location,obo:UBERON_0035549,vasculature of integument,54
obo:RO_0004021,disease caused by disruption of,obo:GO_0006665,sphingolipid metabolic process,53
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006665,sphingolipid metabolic process,53
obo:RO_0004029,disease has feature,obo:MONDO_0005045,hypertrophic cardiomyopathy,53
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000982,skeletal joint,53
obo:RO_0004026,disease has location,obo:UBERON_0001705,nail,53
obo:RO_0004026,disease has location,obo:UBERON_0006562,pharynx,53
obo:RO_0004021,disease caused by disruption of,obo:GO_0032543,mitochondrial translation,52
obo:RO_0004021,disease has basis in disruption of,obo:GO_0032543,mitochondrial translation,52
mondo:disease_has_major_feature,disease has major feature,obo:HP_0010442,Polydactyly,52
obo:RO_0004026,disease has location,obo:UBERON_0000941,cranial nerve II,52
obo:RO_0004026,disease has location,obo:UBERON_0001295,endometrium,52
obo:RO_0004026,disease has location,obo:UBERON_0003703,extrahepatic bile duct,52
obo:RO_0004026,disease has location,obo:UBERON_0010366,conjunctival vasculature,52
obo:RO_0004021,disease caused by disruption of,obo:GO_0006778,porphyrin-containing compound metabolic process,51
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006778,porphyrin-containing compound metabolic process,51
obo:RO_0004021,disease caused by disruption of,obo:GO_0120054,intestinal motility,51
obo:RO_0004021,disease has basis in disruption of,obo:GO_0120054,intestinal motility,51
obo:RO_0002573,has modifier,obo:MONDO_0024491,"tumor grade 1, general grading system",51
obo:RO_0004026,disease has location,obo:UBERON_0000947,aorta,51
obo:RO_0004026,disease has location,obo:UBERON_0000996,vagina,51
obo:RO_0004030,disease arises from structure,obo:CL_0000542,lymphocyte,50
obo:RO_0004024,disease disrupts,obo:GO_0010259,multicellular organism aging,50
obo:RO_0004024,disease causes disruption of,obo:GO_0010259,multicellular organism aging,50
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002459,obsolete Dysautonomia,50
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002459,Dysautonomia,50
obo:RO_0002573,has modifier,obo:PATO_0002129,"neoplastic, invasive",50
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001768,uvea,50
obo:RO_0004026,disease has location,obo:UBERON_0002410,autonomic nervous system,50
obo:RO_0004030,disease arises from structure,obo:UBERON_0006799,glandular epithelium,50
obo:RO_0004026,disease has location,obo:UBERON_0009853,body of uterus,50
obo:RO_0004021,disease caused by disruption of,obo:GO_0030317,flagellated sperm motility,49
obo:RO_0004021,disease has basis in disruption of,obo:GO_0030317,flagellated sperm motility,49
obo:RO_0004024,disease disrupts,obo:GO_0030431,sleep,49
obo:RO_0004024,disease causes disruption of,obo:GO_0030431,sleep,49
mondo:disease_causes_feature,disease causes feature,obo:MONDO_0001106,kidney failure,49
obo:RO_0004026,disease has location,obo:UBERON_0000365,urothelium,49
obo:RO_0004026,disease has location,obo:UBERON_0001756,middle ear,49
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002113,kidney,49
obo:RO_0004026,disease has location,obo:UBERON_0011818,superficial fascia,49
obo:RO_0004021,disease caused by disruption of,obo:GO_0070293,renal absorption,48
obo:RO_0004021,disease has basis in disruption of,obo:GO_0070293,renal absorption,48
obo:RO_0004026,disease has location,obo:UBERON_0001643,oculomotor nerve,48
obo:RO_0004026,disease has location,obo:UBERON_0001769,iris,48
obo:RO_0004026,disease has location,obo:UBERON_0002012,pulmonary artery,48
obo:RO_0004030,disease arises from structure,obo:CL_0000731,urothelial cell,47
obo:RO_0004021,disease caused by disruption of,obo:GO_0003824,catalytic activity,47
obo:RO_0004021,disease has basis in disruption of,obo:GO_0003824,catalytic activity,47
obo:RO_0004021,disease caused by disruption of,obo:GO_0008015,blood circulation,47
obo:RO_0004021,disease has basis in disruption of,obo:GO_0008015,blood circulation,47
obo:RO_0004022,disease arises from feature,obo:MONDO_0004580,retinal degeneration,47
obo:RO_0004022,disease has basis in feature,obo:MONDO_0004580,retinal degeneration,47
obo:RO_0004026,disease has location,obo:UBERON_0000053,macula lutea,47
obo:RO_0004026,disease has location,obo:UBERON_0002110,gall bladder,47
obo:RO_0004024,disease disrupts,obo:GO_0061337,cardiac conduction,46
obo:RO_0004024,disease causes disruption of,obo:GO_0061337,cardiac conduction,46
obo:RO_0004020,disease has basis in dysfunction of,obo:PR_000006537,dystrophin,46
obo:RO_0004030,disease arises from structure,obo:UBERON_0000365,urothelium,46
obo:RO_0004026,disease has location,obo:UBERON_0000974,neck,46
obo:RO_0004026,disease has location,obo:UBERON_0003729,mouth mucosa,46
obo:RO_0004021,disease caused by disruption of,obo:GO_0000002,mitochondrial genome maintenance,45
obo:RO_0004021,disease has basis in disruption of,obo:GO_0000002,mitochondrial genome maintenance,45
obo:RO_0004021,disease caused by disruption of,obo:GO_0005977,glycogen metabolic process,45
obo:RO_0004021,disease has basis in disruption of,obo:GO_0005977,glycogen metabolic process,45
obo:RO_0004021,disease caused by disruption of,obo:GO_0006144,purine nucleobase metabolic process,45
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006144,purine nucleobase metabolic process,45
obo:RO_0004029,disease has feature,obo:HP_0002789,Tachypnea,45
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_10292,Herpesviridae,45
obo:RO_0004026,disease has location,obo:UBERON_0000017,exocrine pancreas,45
obo:RO_0004026,disease has location,obo:UBERON_0001846,internal ear,45
obo:RO_0004030,disease arises from structure,obo:UBERON_0002346,neurectoderm,45
obo:RO_0004026,disease has location,obo:UBERON_0003889,fallopian tube,45
obo:RO_0004026,disease has location,obo:UBERON_0001911,mammary gland,44
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005581,collagen trimer,43
obo:RO_0004024,disease disrupts,obo:GO_0006486,protein glycosylation,43
obo:RO_0004024,disease causes disruption of,obo:GO_0006486,protein glycosylation,43
mondo:disease_has_major_feature,disease has major feature,obo:HP_0006705,Abnormal atrioventricular valve morphology,43
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1773,Mycobacterium tuberculosis,43
obo:RO_0004020,disease has basis in dysfunction of,obo:PR_000015322,alpha-synuclein,43
obo:RO_0004026,disease has location,obo:UBERON_0001245,anus,43
obo:RO_0004026,disease has location,obo:UBERON_0002133,atrioventricular valve,43
obo:RO_0004022,disease arises from feature,obo:HP_0000133,Gonadal dysgenesis,42
obo:RO_0004022,disease has basis in feature,obo:HP_0000133,Gonadal dysgenesis,42
obo:RO_0004029,disease has feature,obo:HP_0000478,Abnormality of the eye,42
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000924,Abnormality of the skeletal system,42
obo:RO_0004029,disease has feature,obo:HP_0001597,Abnormality of the nail,42
obo:RO_0004029,disease has feature,obo:HP_0001735,Acute pancreatitis,42
mondo:disease_has_major_feature,disease has major feature,obo:HP_0007435,Diffuse palmoplantar keratoderma,42
obo:RO_0004029,disease has feature,obo:MONDO_0006515,acute pancreatitis,42
obo:RO_0004026,disease has location,obo:UBERON_0002370,thymus,42
obo:RO_0004030,disease arises from structure,obo:CL_0000084,T cell,41
obo:RO_0002573,has modifier,obo:SO_1000008,point_mutation,41
obo:RO_0004026,disease has location,obo:UBERON_0000057,urethra,41
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000160,intestine,41
obo:RO_0004030,disease arises from structure,obo:UBERON_0004801,cervix epithelium,41
obo:RO_0004026,disease has location,obo:CL_0000019,sperm,40
obo:RO_0004021,disease caused by disruption of,obo:GO_0001843,neural tube closure,40
obo:RO_0004021,disease has basis in disruption of,obo:GO_0001843,neural tube closure,40
obo:RO_0004024,disease disrupts,obo:GO_0050892,intestinal absorption,40
obo:RO_0004024,disease causes disruption of,obo:GO_0050892,intestinal absorption,40
obo:RO_0004029,disease has feature,obo:HP_0000093,Proteinuria,40
obo:RO_0004029,disease has feature,obo:HP_0000969,Edema,40
obo:RO_0004029,disease has feature,obo:HP_0003073,Hypoalbuminemia,40
obo:RO_0002573,has modifier,obo:MONDO_0045035,opportunistic infectious,40
obo:RO_0004026,disease has location,obo:UBERON_0006742,canthus,40
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000618,Blindness,39
obo:RO_0004029,disease has feature,obo:HP_0007354,Amyotrophic lateral sclerosis,39
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000344,mucosa,39
obo:RO_0004026,disease has location,obo:UBERON_0001130,vertebral column,39
obo:RO_0004029,disease has feature,obo:HP_0000099,Glomerulonephritis,38
mondo:disease_has_major_feature,disease has major feature,obo:HP_0009125,Lipodystrophy,38
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_203691,Spirochaetes,38
obo:RO_0004026,disease has location,obo:UBERON_0001027,sensory nerve,38
obo:RO_0004026,disease has location,obo:UBERON_0001776,optic choroid,38
obo:RO_0004026,disease has location,obo:CL_0000244,transitional epithelial cell,37
obo:RO_0004024,disease disrupts,obo:GO_0006631,fatty acid metabolic process,37
obo:RO_0004024,disease causes disruption of,obo:GO_0006631,fatty acid metabolic process,37
obo:RO_0004029,disease has feature,obo:MONDO_0005872,nervous system cancer,37
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_766,Rickettsiales,37
obo:RO_0004026,disease has location,obo:UBERON_0001758,periodontium,37
obo:RO_0004026,disease has location,obo:UBERON_0003728,mediastinum,37
obo:RO_0004028,realized in response to stimulus,obo:FOODON_00002403,food material,36
obo:RO_0004021,disease caused by disruption of,obo:GO_0016125,sterol metabolic process,36
obo:RO_0004021,disease has basis in disruption of,obo:GO_0016125,sterol metabolic process,36
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_6231,Nematoda,36
obo:RO_0002573,has modifier,obo:PATO_0002092,anaplastic,36
obo:RO_0004026,disease has location,obo:UBERON_0000056,ureter,36
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000964,cornea,36
obo:RO_0004026,disease has location,obo:UBERON_0000989,penis,36
obo:RO_0004030,disease arises from structure,obo:CL_0000669,pericyte cell,35
obo:RO_0004021,disease caused by disruption of,obo:GO_0006956,complement activation,35
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006956,complement activation,35
obo:RO_0004029,disease has feature,obo:HP_0003473,Fatigable weakness,35
obo:RO_0004029,disease has feature,obo:MONDO_0018398,female infertility due to a congenital hypogonadotropic hypogonadism,35
obo:RO_0002573,has modifier,obo:MONDO_0022202,disseminated,35
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001811,conjunctiva,35
obo:RO_0004021,disease caused by disruption of,obo:GO_0001755,neural crest cell migration,34
obo:RO_0004021,disease has basis in disruption of,obo:GO_0001755,neural crest cell migration,34
obo:RO_0004021,disease caused by disruption of,obo:GO_0007265,Ras protein signal transduction,34
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007265,Ras protein signal transduction,34
obo:RO_0004026,disease has location,obo:UBERON_0000383,musculature of body,34
obo:RO_0004030,disease arises from structure,obo:UBERON_0000924,ectoderm,34
obo:RO_0004026,disease has location,obo:UBERON_0001153,caecum,34
obo:RO_0004026,disease has location,obo:UBERON_0002114,duodenum,34
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002385,muscle tissue,34
obo:RO_0004021,disease caused by disruption of,obo:GO_0006766,vitamin metabolic process,33
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006766,vitamin metabolic process,33
obo:RO_0004024,disease disrupts,obo:GO_0008015,blood circulation,33
obo:RO_0004024,disease causes disruption of,obo:GO_0008015,blood circulation,33
obo:RO_0004029,disease has feature,obo:HP_0002145,Frontotemporal dementia,33
obo:RO_0002573,has modifier,obo:MONDO_0024492,"tumor grade 2, general grading system",33
obo:RO_0004026,disease has location,obo:UBERON_0001797,vitreous humor,33
obo:RO_0004026,disease has location,obo:UBERON_0003499,brain blood vessel,33
obo:RO_0004030,disease arises from structure,obo:CL_0000646,basal cell,32
obo:RO_0009501,realized in response to,obo:ECTO_0000509,exposure to drug,32
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000951,Abnormality of the skin,32
obo:RO_0004029,disease has feature,obo:HP_0000988,Skin rash,32
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002315,Headache,32
obo:RO_0002573,has modifier,obo:MONDO_0045042,localized,32
obo:RO_0004026,disease has location,obo:UBERON_0001638,vein,32
obo:RO_0004030,disease arises from structure,obo:UBERON_0002384,connective tissue,32
obo:RO_0004026,disease has location,obo:UBERON_0003126,trachea,32
obo:RO_0004026,disease has location,obo:UBERON_0004864,vasculature of retina,32
obo:RO_0004021,disease caused by disruption of,obo:GO_0006487,protein N-linked glycosylation,31
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006487,protein N-linked glycosylation,31
obo:RO_0002573,has modifier,obo:HP_0003623,Neonatal onset,31
obo:RO_0004029,disease has feature,obo:MONDO_0019833,pituitary hormone deficiency from tumoral origin,31
obo:RO_0004026,disease has location,obo:CL_0000127,astrocyte,30
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005652,nuclear lamina,30
obo:RO_0004024,disease disrupts,obo:GO_0038023,signaling receptor activity,30
obo:RO_0004024,disease causes disruption of,obo:GO_0038023,signaling receptor activity,30
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000271,Abnormality of the face,30
mondo:disease_has_major_feature,disease has major feature,obo:HP_0010524,Agnosia,30
obo:RO_0002573,has modifier,obo:HP_0025153,Transient,30
obo:RO_0004024,disease disrupts,obo:NBO_0000551,visual object recognition,30
obo:RO_0004024,disease causes disruption of,obo:NBO_0000551,visual object recognition,30
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_157,Treponema,30
obo:RO_0004029,disease has feature,obo:HP_0002716,Lymphadenopathy,29
obo:RO_0004029,disease has feature,obo:HP_0006530,Interstitial pulmonary abnormality,29
mondo:disease_has_major_feature,disease has major feature,obo:HP_0007370,Aplasia/Hypoplasia of the corpus callosum,29
obo:RO_0004029,disease has feature,obo:HP_0011675,Arrhythmia,29
obo:RO_0004022,disease arises from feature,obo:HP_0011962,Obstructive azoospermia,29
obo:RO_0004022,disease has basis in feature,obo:HP_0011962,Obstructive azoospermia,29
obo:RO_0004024,disease disrupts,obo:MFOEM_000193,mood process,29
obo:RO_0004024,disease causes disruption of,obo:MFOEM_000193,mood process,29
obo:RO_0004029,disease has feature,obo:MONDO_0006547,exanthem (disease),29
obo:RO_0004026,disease has location,obo:UBERON_0001869,cerebral hemisphere,29
obo:RO_0004026,disease has location,obo:UBERON_0005295,sex cord,29
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000097,mast cell,28
obo:RO_0004030,disease arises from structure,obo:CL_0011012,neural crest cell,28
obo:RO_0004024,disease disrupts,obo:GO_0015723,bilirubin transport,28
obo:RO_0004024,disease causes disruption of,obo:GO_0015723,bilirubin transport,28
obo:RO_0004024,disease disrupts,obo:GO_0043217,myelin maintenance,28
obo:RO_0004024,disease causes disruption of,obo:GO_0043217,myelin maintenance,28
obo:RO_0004029,disease has feature,obo:HP_0000113,Polycystic kidney dysplasia,28
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000202,Oral cleft,28
mondo:disease_has_major_feature,disease has major feature,obo:HP_0003077,Hyperlipidemia,28
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0005129,cataract (disease),28
obo:RO_0002573,has modifier,obo:SO_1000037,chromosomal_duplication,28
obo:RO_0004026,disease has location,obo:UBERON_0000088,trophoblast,28
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001756,middle ear,28
obo:RO_0004026,disease has location,obo:UBERON_0002106,spleen,28
obo:RO_0004026,disease has location,obo:UBERON_0002185,bronchus,28
mondo:disease_has_basis_in_development_of,disease_has_basis_in_development_of,obo:UBERON_0012314,embryonic facial prominence,28
obo:RO_0004026,disease has location,obo:CL_0000222,mesodermal cell,27
obo:RO_0009501,realized in response to,obo:ECTO_0000259,exposure to glucocorticoid,27
obo:RO_0004021,disease caused by disruption of,obo:GO_0000096,sulfur amino acid metabolic process,27
obo:RO_0004021,disease has basis in disruption of,obo:GO_0000096,sulfur amino acid metabolic process,27
obo:RO_0004022,disease arises from feature,obo:HP_0001877,Abnormal erythrocyte morphology,27
obo:RO_0004022,disease has basis in feature,obo:HP_0001877,Abnormal erythrocyte morphology,27
obo:RO_0004029,disease has feature,obo:HP_0002090,Pneumonia,27
obo:RO_0004026,disease has location,obo:UBERON_0000977,pleura,27
obo:RO_0004026,disease has location,obo:UBERON_0001829,major salivary gland,27
obo:RO_0004026,disease has location,obo:UBERON_0002360,meninx,27
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002360,meninx,27
obo:RO_0004026,disease has location,obo:UBERON_0003693,retroperitoneal space,27
obo:RO_0004030,disease arises from structure,obo:UBERON_0004670,ependyma,27
obo:RO_0004030,disease arises from structure,obo:CL_0000138,chondrocyte,26
obo:RO_0004030,disease arises from structure,obo:CL_0000786,plasma cell,26
obo:RO_0004024,disease disrupts,obo:GO_0055074,calcium ion homeostasis,26
obo:RO_0004024,disease causes disruption of,obo:GO_0055074,calcium ion homeostasis,26
obo:RO_0004029,disease has feature,obo:HP_0002185,Neurofibrillary tangles,26
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_160,Treponema pallidum,26
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_485,Neisseria gonorrhoeae,26
obo:RO_0004030,disease arises from structure,obo:UBERON_0000160,intestine,26
obo:RO_0004030,disease arises from structure,obo:UBERON_0001013,adipose tissue,26
obo:RO_0004026,disease has location,obo:UBERON_0001785,cranial nerve,26
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000169,type B pancreatic cell,25
obo:BFO_0000054,realized in,obo:GO_0019233,sensory perception of pain,25
obo:RO_0004021,disease caused by disruption of,obo:GO_0035773,insulin secretion involved in cellular response to glucose stimulus,25
obo:RO_0004021,disease has basis in disruption of,obo:GO_0035773,insulin secretion involved in cellular response to glucose stimulus,25
obo:RO_0004021,disease caused by disruption of,obo:GO_1903510,mucopolysaccharide metabolic process,25
obo:RO_0004021,disease has basis in disruption of,obo:GO_1903510,mucopolysaccharide metabolic process,25
obo:RO_0004024,disease disrupts,obo:GO_1990542,mitochondrial transmembrane transport,25
obo:RO_0004024,disease causes disruption of,obo:GO_1990542,mitochondrial transmembrane transport,25
obo:RO_0004029,disease has feature,obo:HP_0000964,Eczema,25
obo:RO_0004029,disease has feature,obo:HP_0001287,Meningitis,25
obo:RO_0004029,disease has feature,obo:HP_0001369,Arthritis,25
obo:RO_0004022,disease arises from feature,obo:HP_0006476,Abnormality of the pancreatic islet cells,25
obo:RO_0004022,disease has basis in feature,obo:HP_0006476,Abnormality of the pancreatic islet cells,25
mondo:disease_has_major_feature,disease has major feature,obo:HP_0012531,Pain,25
obo:RO_0004029,disease has feature,obo:MONDO_0003778,primary immunodeficiency disease,25
mondo:disease_causes_feature,disease causes feature,obo:MONDO_0012819,diabetic ketoacidosis,25
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_11050,Flaviviridae,25
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_11157,Mononegavirales,25
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_12058,Picornaviridae,25
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_775,Rickettsiaceae,25
obo:RO_0004026,disease has location,obo:UBERON_0000956,cerebral cortex,25
obo:RO_0004026,disease has location,obo:UBERON_0001707,nasal cavity,25
obo:RO_0004026,disease has location,obo:UBERON_0001765,mammary duct,25
obo:RO_0004027,disease has inflammation site,obo:UBERON_0010230,eyeball of camera-type eye,25
obo:RO_0004020,disease has basis in dysfunction of,hgnc:6342,KIT,24
obo:RO_0004021,disease caused by disruption of,obo:GO_0006506,GPI anchor biosynthetic process,24
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006506,GPI anchor biosynthetic process,24
obo:RO_0004029,disease has feature,obo:HP_0000842,Hyperinsulinemia,24
obo:RO_0004029,disease has feature,obo:HP_0001433,Hepatosplenomegaly,24
mondo:disease_causes_feature,disease causes feature,obo:HP_0001944,Dehydration,24
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002014,Diarrhea,24
obo:RO_0004029,disease has feature,obo:HP_0002373,Febrile seizures,24
obo:RO_0004026,disease has location,obo:UBERON_0000029,lymph node,24
obo:RO_0004026,disease has location,obo:UBERON_0000178,blood,24
obo:RO_0004026,disease has location,obo:UBERON_0000403,scalp,24
obo:RO_0004026,disease has location,obo:UBERON_0001154,vermiform appendix,24
obo:RO_0004026,disease has location,obo:UBERON_0001828,gingiva,24
obo:RO_0004026,disease has location,obo:UBERON_0001894,diencephalon,24
obo:RO_0004026,disease has location,obo:UBERON_0001987,placenta,24
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002107,liver,24
obo:RO_0004026,disease has location,obo:UBERON_0002407,pericardium,24
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005585,collagen type II trimer,23
obo:BFO_0000054,realized in,obo:GO_0046879,hormone secretion,23
obo:RO_0004029,disease has feature,obo:MONDO_0001147,meningocele (disease),23
obo:RO_0004029,disease has feature,obo:MONDO_0005478,torsades de pointes,23
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_780,Rickettsia,23
obo:RO_0004026,disease has location,obo:UBERON_0001235,adrenal cortex,23
obo:RO_0004026,disease has location,obo:UBERON_0001621,coronary artery,23
obo:RO_0004026,disease has location,obo:UBERON_0001821,sebaceous gland,23
obo:RO_0004026,disease has location,obo:UBERON_0003100,female organism,23
obo:RO_0004030,disease arises from structure,obo:CL_0002573,Schwann cell,22
obo:RO_0004021,disease caused by disruption of,obo:GO_0006694,steroid biosynthetic process,22
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006694,steroid biosynthetic process,22
obo:RO_0004021,disease caused by disruption of,obo:GO_0007283,spermatogenesis,22
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007283,spermatogenesis,22
obo:RO_0004021,disease caused by disruption of,obo:GO_0019395,fatty acid oxidation,22
obo:RO_0004021,disease has basis in disruption of,obo:GO_0019395,fatty acid oxidation,22
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001159,Syndactyly,22
obo:RO_0004029,disease has feature,obo:HP_0001159,Syndactyly,22
obo:RO_0004029,disease has feature,obo:HP_0001700,Myocardial necrosis,22
obo:RO_0004029,disease has feature,obo:HP_0100512,Low levels of vitamin D,22
obo:RO_0004029,disease has feature,obo:HP_0100512,Vitamin D deficiency,22
mondo:predisposes_towards,predisposes towards,obo:MONDO_0005550,infectious disease,22
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_12059,Enterovirus,22
obo:RO_0004029,disease has feature,obo:NCIT_C37109,Malignant Epithelial Spindle Cell,22
obo:RO_0004026,disease has location,obo:UBERON_0001905,pineal body,22
obo:RO_0004026,disease has location,obo:UBERON_0002358,peritoneum,22
obo:RO_0009501,realized in response to,obo:ECTO_0001082,NA,21
obo:RO_0004021,disease caused by disruption of,obo:GO_0006090,pyruvate metabolic process,21
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006090,pyruvate metabolic process,21
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0042827,platelet dense granule,21
obo:RO_0004029,disease has feature,obo:HP_0000238,Hydrocephalus,21
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002047,Malignant hyperthermia,21
obo:RO_0004029,disease has feature,obo:HP_0002094,Dyspnea,21
mondo:disease_has_major_feature,disease has major feature,obo:HP_0002486,Myotonia,21
obo:RO_0004024,disease disrupts,obo:NBO_0000034,sexual activity,21
obo:RO_0004024,disease causes disruption of,obo:NBO_0000034,sexual activity,21
obo:RO_0004024,disease disrupts,obo:NBO_0000612,communication behavior,21
obo:RO_0004024,disease causes disruption of,obo:NBO_0000612,communication behavior,21
obo:RO_0004026,disease has location,obo:UBERON_0000211,ligament,21
obo:RO_0004026,disease has location,obo:UBERON_0007616,layer of synovial tissue,21
obo:RO_0004030,disease arises from structure,obo:CL_0000031,neuroblast,20
obo:RO_0004030,disease arises from structure,obo:CL_0000354,blastemal cell,20
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000775,neutrophil,20
obo:RO_0004029,disease has feature,obo:HP_0000939,Osteoporosis,20
obo:RO_0004029,disease has feature,obo:HP_0001276,Hypertonia,20
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001679,Abnormal aortic morphology,20
obo:RO_0004029,disease has feature,obo:MONDO_0006651,anterior uveitis (disease),20
obo:RO_0004026,disease has location,obo:UBERON_0000043,tendon,20
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000403,scalp,20
obo:RO_0004026,disease has location,obo:UBERON_0001691,external ear,20
obo:RO_0004026,disease has location,obo:UBERON_0001729,oropharynx,20
obo:RO_0004026,disease has location,obo:UBERON_0001908,optic tract,20
obo:RO_0004026,disease has location,obo:UBERON_0002298,brainstem,20
obo:RO_0004030,disease arises from structure,obo:CL_0000235,macrophage,19
obo:RO_0004030,disease arises from structure,obo:CL_0002293,epithelial cell of thymus,19
obo:RO_0009501,realized in response to,obo:ECTO_0000002,exposure to electromagnetic radiation,19
obo:RO_0004021,disease caused by disruption of,obo:GO_0000050,urea cycle,19
obo:RO_0004021,disease has basis in disruption of,obo:GO_0000050,urea cycle,19
obo:RO_0004021,disease caused by disruption of,obo:GO_0009311,oligosaccharide metabolic process,19
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009311,oligosaccharide metabolic process,19
obo:RO_0004029,disease has feature,obo:HP_0000522,Alacrima,19
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001635,Congestive heart failure,19
obo:RO_0004029,disease has feature,obo:HP_0001876,Pancytopenia,19
obo:RO_0004022,disease arises from feature,obo:MONDO_0005070,neoplasm (disease),19
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005070,neoplasm (disease),19
obo:RO_0002451,transmitted by,obo:NCBITaxon_6944,Ixodes,19
obo:BFO_0000054,realized in,obo:NCIT_C17214,Disease Transmission,19
obo:RO_0004028,realized in response to stimulus,obo:PR_000001886,major prion protein,19
obo:RO_0004026,disease has location,obo:UBERON_0000423,eccrine sweat gland,19
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001155,colon,19
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001173,biliary tree,19
obo:RO_0004026,disease has location,obo:UBERON_0001708,jaw skeleton,19
obo:RO_0004026,disease has location,obo:UBERON_0001810,nerve plexus,19
obo:RO_0004026,disease has location,obo:UBERON_0002081,cardiac atrium,19
obo:RO_0004026,disease has location,obo:UBERON_0002082,cardiac ventricle,19
obo:RO_0004026,disease has location,obo:UBERON_0003101,male organism,19
obo:RO_0004026,disease has location,obo:UBERON_0004367,Descemet's membrane,19
obo:RO_0004020,disease has basis in dysfunction of,hgnc:2200,COL2A1,18
obo:RO_0004020,disease has basis in dysfunction of,hgnc:3512,EXT1,18
obo:RO_0004024,disease disrupts,obo:GO_0007585,respiratory gaseous exchange by respiratory system,18
obo:RO_0004024,disease disrupts,obo:GO_0007585,respiratory gaseous exchange,18
obo:RO_0004024,disease causes disruption of,obo:GO_0007585,respiratory gaseous exchange by respiratory system,18
obo:RO_0004024,disease causes disruption of,obo:GO_0007585,respiratory gaseous exchange,18
obo:RO_0004021,disease caused by disruption of,obo:GO_0042403,thyroid hormone metabolic process,18
obo:RO_0004021,disease has basis in disruption of,obo:GO_0042403,thyroid hormone metabolic process,18
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0098975,postsynapse of neuromuscular junction,18
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000843,Hyperparathyroidism,18
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001336,Myoclonus,18
obo:RO_0004029,disease has feature,obo:HP_0002019,Constipation,18
obo:RO_0004029,disease has feature,obo:MONDO_0002203,constipation disorder,18
obo:RO_0004020,disease has basis in dysfunction of,obo:PR_000007547,fukutin-related protein,18
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000945,stomach,18
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001255,urinary bladder,18
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001711,eyelid,18
obo:RO_0004026,disease has location,obo:UBERON_0001775,ciliary body,18
obo:RO_0004026,disease has location,obo:UBERON_0001817,lacrimal gland,18
obo:RO_0004030,disease arises from structure,obo:UBERON_0001982,capillary,18
obo:RO_0004026,disease has location,obo:UBERON_0002350,conducting system of heart,18
obo:RO_0004027,disease has inflammation site,obo:UBERON_0005983,heart layer,18
obo:RO_0004024,disease disrupts,obo:GO_0006911,"phagocytosis, engulfment",17
obo:RO_0004024,disease causes disruption of,obo:GO_0006911,"phagocytosis, engulfment",17
obo:RO_0004021,disease caused by disruption of,obo:GO_0009069,serine family amino acid metabolic process,17
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009069,serine family amino acid metabolic process,17
obo:RO_0004021,disease caused by disruption of,obo:GO_0009081,branched-chain amino acid metabolic process,17
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009081,branched-chain amino acid metabolic process,17
obo:RO_0004021,disease caused by disruption of,obo:GO_0009235,cobalamin metabolic process,17
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009235,cobalamin metabolic process,17
obo:RO_0002573,has modifier,obo:HP_0003621,Juvenile onset,17
obo:RO_0004029,disease has feature,obo:HP_0004313,Decreased antibody level in blood,17
obo:RO_0004029,disease has feature,obo:HP_0100502,Vitamin B12 deficiency,17
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0015923,acquired peripheral neuropathy,17
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0017672,focal palmoplantar keratoderma,17
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_10294,Simplexvirus,17
obo:RO_0004029,disease has feature,obo:NCIT_C53637,Malignant Spindle Cell,17
obo:RO_0004020,disease has basis in dysfunction of,obo:PR_000013016,"protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1",17
obo:RO_0004026,disease has location,obo:UBERON_0000382,apocrine sweat gland,17
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000474,female reproductive system,17
obo:RO_0004026,disease has location,obo:UBERON_0001772,corneal epithelium,17
obo:RO_0004026,disease has location,obo:UBERON_0001773,sclera,17
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002355,pelvic region of trunk,17
obo:RO_0004026,disease has location,obo:UBERON_0002418,cartilage tissue,17
obo:RO_0004027,disease has inflammation site,obo:UBERON_0008946,lung parenchyma,17
obo:RO_0004027,disease has inflammation site,obo:UBERON_0019207,chorioretinal region,17
obo:RO_0004030,disease arises from structure,obo:CL_0000185,myoepithelial cell,16
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000829,Hypoparathyroidism,16
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001392,Abnormality of the liver,16
obo:RO_0004029,disease has feature,obo:HP_0002721,Immunodeficiency,16
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1279,Staphylococcus,16
obo:RO_0002573,has modifier,obo:PATO_0002098,"neoplastic, metastatic",16
obo:RO_0004026,disease has location,obo:UBERON_0001723,tongue,16
obo:RO_0004026,disease has location,obo:UBERON_0001728,nasopharynx,16
obo:RO_0004026,disease has location,obo:UBERON_0002134,tricuspid valve,16
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0002369,adrenal gland,16
obo:RO_0004020,disease has basis in dysfunction of,hgnc:9884,RB1,15
obo:RO_0004030,disease arises from structure,obo:CL_1001428,bladder urothelial cell,15
obo:RO_0004021,disease caused by disruption of,obo:GO_0006699,bile acid biosynthetic process,15
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006699,bile acid biosynthetic process,15
obo:RO_0004021,disease caused by disruption of,obo:GO_0006826,iron ion transport,15
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006826,iron ion transport,15
obo:RO_0004021,disease caused by disruption of,obo:GO_0061370,testosterone biosynthetic process,15
obo:RO_0004021,disease has basis in disruption of,obo:GO_0061370,testosterone biosynthetic process,15
obo:RO_0004029,disease has feature,obo:HP_0000750,Delayed speech and language development,15
obo:RO_0004029,disease has feature,obo:HP_0000830,Anterior hypopituitarism,15
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001305,Dandy-Walker malformation,15
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001627,Abnormal heart morphology,15
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001880,Eosinophilia,15
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_11158,Paramyxoviridae,15
obo:RO_0004029,disease has feature,obo:NCIT_C45981,Presence of a Hormonal Syndrome,15
obo:RO_0004030,disease arises from structure,obo:UBERON_0000991,gonad,15
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001021,nerve,15
obo:RO_0004026,disease has location,obo:UBERON_0001174,common bile duct,15
obo:RO_0004030,disease arises from structure,obo:UBERON_0001207,mucosa of large intestine,15
obo:RO_0004026,disease has location,obo:UBERON_0001280,liver parenchyma,15
obo:RO_0004026,disease has location,obo:UBERON_0001833,lip,15
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002046,thyroid gland,15
obo:RO_0004026,disease has location,obo:UBERON_0002196,adenohypophysis,15
obo:RO_0004026,disease has location,obo:UBERON_0004086,brain ventricle,15
obo:RO_0004030,disease arises from structure,obo:UBERON_0006914,squamous epithelium,15
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0008998,vasculature of brain,15
obo:RO_0004030,disease arises from structure,obo:CL_0000451,dendritic cell,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0001806,type IV hypersensitivity,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0001806,type IV hypersensitivity,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0006289,nucleotide-excision repair,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006289,nucleotide-excision repair,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0015693,magnesium ion transport,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0015693,magnesium ion transport,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0016126,sterol biosynthetic process,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0016126,sterol biosynthetic process,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0050667,homocysteine metabolic process,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0050667,homocysteine metabolic process,14
obo:RO_0004021,disease caused by disruption of,obo:GO_0070914,UV-damage excision repair,14
obo:RO_0004021,disease has basis in disruption of,obo:GO_0070914,UV-damage excision repair,14
mondo:disease_has_major_feature,disease has major feature,obo:HP_0000286,Epicanthus,14
obo:RO_0004029,disease has feature,obo:HP_0000297,Facial hypotonia,14
obo:RO_0004029,disease has feature,obo:HP_0002072,Chorea,14
mondo:disease_has_major_feature,disease has major feature,obo:HP_0011842,Abnormality of skeletal morphology,14
obo:RO_0002573,has modifier,obo:HP_0031375,Refractory,14
obo:RO_0004029,disease has feature,obo:HP_0100257,Ectrodactyly,14
obo:RO_0004029,disease has feature,obo:HP_0100324,Scleroderma,14
mondo:predisposes_towards,predisposes towards,obo:MONDO_0002026,candidiasis,14
obo:RO_0004029,disease has feature,obo:MONDO_0004617,recurrent hypersomnia,14
obo:RO_0004029,disease has feature,obo:MONDO_0005170,myeloid neoplasm,14
obo:RO_0004029,disease has feature,obo:MONDO_0019289,hyperpigmentation of the skin,14
obo:RO_0004029,disease has feature,obo:MONDO_0021138,bone marrow cancer,14
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1485,Clostridium,14
obo:RO_0004030,disease arises from structure,obo:UBERON_0000992,ovary,14
obo:RO_0004030,disease arises from structure,obo:UBERON_0000992,female gonad,14
obo:RO_0004026,disease has location,obo:UBERON_0001224,renal pelvis,14
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001637,artery,14
obo:RO_0004026,disease has location,obo:UBERON_0001777,substantia propria of cornea,14
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001825,paranasal sinus,14
obo:RO_0004026,disease has location,obo:UBERON_0002137,aortic valve,14
obo:RO_0004026,disease has location,obo:UBERON_0005305,thyroid follicle,14
obo:RO_0004020,disease has basis in dysfunction of,hgnc:5009,HMGA2,13
obo:RO_0004026,disease has location,obo:CL_0000182,hepatocyte,13
obo:RO_0004020,disease has basis in dysfunction of,obo:CL_0000573,retinal cone cell,13
obo:RO_0004021,disease caused by disruption of,obo:GO_0009107,lipoate biosynthetic process,13
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009107,lipoate biosynthetic process,13
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0019814,immunoglobulin complex,13
obo:RO_0004029,disease has feature,obo:HP_0001510,Growth delay,13
mondo:disease_has_major_feature,disease has major feature,obo:HP_0001702,Abnormal tricuspid valve morphology,13
obo:RO_0004029,disease has feature,obo:HP_0002224,Woolly hair,13
obo:RO_0004029,disease has feature,obo:HP_0002917,Hypomagnesemia,13
obo:RO_0004029,disease has feature,obo:HP_0002960,Autoimmunity,13
obo:RO_0004029,disease has feature,obo:HP_0003510,Severe short stature,13
obo:RO_0004029,disease has feature,obo:HP_0009830,Peripheral neuropathy,13
obo:RO_0004029,disease has feature,obo:HP_0010514,Hyperpituitarism,13
obo:RO_0004022,disease arises from feature,obo:MONDO_0005187,human herpesvirus 8 infection,13
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005187,human herpesvirus 8 infection,13
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000029,lymph node,13
obo:RO_0004027,disease has inflammation site,obo:UBERON_0000042,serous membrane,13
obo:RO_0004026,disease has location,obo:UBERON_0000058,duct,13
obo:RO_0004026,disease has location,obo:UBERON_0001051,hypopharynx,13
obo:RO_0004030,disease arises from structure,obo:UBERON_0001765,mammary duct,13
obo:RO_0004026,disease has location,obo:UBERON_0002025,stratum basale of epidermis,13
obo:RO_0004026,disease has location,obo:UBERON_0002135,mitral valve,13
obo:RO_0004027,disease has inflammation site,obo:UBERON_0003889,fallopian tube,13
obo:RO_0004026,disease has location,obo:UBERON_0005777,glomerular basement membrane,13
obo:RO_0004020,disease has basis in dysfunction of,hgnc:10964,SLC22A18,12
obo:RO_0004020,disease has basis in dysfunction of,hgnc:11117,SMN1,12
obo:RO_0004030,disease arises from structure,obo:CL_0000182,hepatocyte,12
obo:RO_0004030,disease arises from structure,obo:CL_0000210,photoreceptor cell,12
obo:RO_0004021,disease caused by disruption of,obo:GO_0006558,L-phenylalanine metabolic process,12
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006558,L-phenylalanine metabolic process,12
obo:RO_0004021,disease caused by disruption of,obo:GO_0007041,lysosomal transport,12
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007041,lysosomal transport,12
obo:RO_0004021,disease caused by disruption of,obo:GO_0007623,circadian rhythm,12
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007623,circadian rhythm,12
obo:RO_0004024,disease disrupts,obo:GO_0045453,bone resorption,12
obo:RO_0004024,disease causes disruption of,obo:GO_0045453,bone resorption,12
obo:RO_0004029,disease has feature,obo:HP_0000096,Glomerulosclerosis,12
mondo:disease_has_major_feature,disease has major feature,obo:HP_0010980,Hyperlipoproteinemia,12
obo:RO_0004022,disease arises from feature,obo:MONDO_0005015,diabetes mellitus (disease),12
obo:RO_0004022,disease has basis in feature,obo:MONDO_0005015,diabetes mellitus (disease),12
mondo:disease_has_major_feature,disease has major feature,obo:MONDO_0018912,Cushing syndrome,12
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_11617,Arenaviridae,12
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1301,Streptococcus,12
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1535326,Candida <Debaryomycetaceae>,12
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_6199,Cestoda,12
obo:RO_0004029,disease has feature,obo:NCIT_C37123,Neoplastic Spindle-Shaped to Round Cell,12
obo:RO_0004026,disease has location,obo:UBERON_0000460,major vestibular gland,12
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0000992,ovary,12
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0000992,female gonad,12
obo:RO_0004026,disease has location,obo:UBERON_0001021,nerve,12
obo:RO_0004026,disease has location,obo:UBERON_0001236,adrenal medulla,12
obo:RO_0004026,disease has location,obo:UBERON_0001300,scrotum,12
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001758,periodontium,12
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002240,spinal cord,12
obo:RO_0004026,disease has location,obo:UBERON_0002387,pes,12
obo:RO_0004027,disease has inflammation site,obo:UBERON_0003729,mouth mucosa,12
obo:RO_0004030,disease arises from structure,obo:UBERON_0003902,retinal neural layer,12
obo:RO_0004030,disease arises from structure,obo:UBERON_0004645,urinary bladder urothelium,12
obo:RO_0004020,disease has basis in dysfunction of,hgnc:3690,FGFR3,11
obo:RO_0004020,disease has basis in dysfunction of,hgnc:6636,LMNA,11
obo:RO_0004026,disease has location,obo:CL_0000622,acinar cell,11
obo:RO_0004026,disease has location,obo:CL_0000771,eosinophil,11
obo:RO_0004026,disease has location,obo:CL_0002063,type II pneumocyte,11
obo:RO_0004028,realized in response to stimulus,obo:FOODON_03315468,shellfish meat (whole or parts),11
obo:RO_0004021,disease caused by disruption of,obo:GO_0004887,thyroid hormone receptor activity,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0004887,thyroid hormone receptor activity,11
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005592,collagen type XI trimer,11
obo:RO_0004026,disease has location,obo:GO_0005604,basement membrane,11
obo:RO_0004020,disease has basis in dysfunction of,obo:GO_0005750,mitochondrial respiratory chain complex III,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0006206,pyrimidine nucleobase metabolic process,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006206,pyrimidine nucleobase metabolic process,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0006560,proline metabolic process,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0006560,proline metabolic process,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0007499,ectoderm and mesoderm interaction,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007499,ectoderm and mesoderm interaction,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0007566,embryo implantation,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0007566,embryo implantation,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0009066,aspartate family amino acid metabolic process,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0009066,aspartate family amino acid metabolic process,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0035932,aldosterone secretion,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0035932,aldosterone secretion,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0071696,ectodermal placode development,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0071696,ectodermal placode development,11
obo:RO_0004021,disease caused by disruption of,obo:GO_0093001,glycolysis from storage polysaccharide through glucose-1-phosphate,11
obo:RO_0004021,disease has basis in disruption of,obo:GO_0093001,glycolysis from storage polysaccharide through glucose-1-phosphate,11
obo:RO_0004029,disease has feature,obo:HP_0000230,Gingivitis,11
obo:RO_0004029,disease has feature,obo:HP_0000966,Hypohidrosis,11
obo:RO_0004029,disease has feature,obo:HP_0001249,Intellectual disability,11
obo:RO_0004029,disease has feature,obo:HP_0002148,Hypophosphatemia,11
obo:RO_0004022,disease arises from feature,obo:HP_0002619,Varicose veins,11
obo:RO_0004022,disease has basis in feature,obo:HP_0002619,Varicose veins,11
obo:RO_0004029,disease has feature,obo:HP_0002904,Hyperbilirubinemia,11
obo:RO_0004029,disease has feature,obo:HP_0003351,Decreased circulating renin level,11
obo:RO_0004029,disease has feature,obo:HP_0003470,Paralysis,11
obo:RO_0002573,has modifier,obo:HP_0003577,Congenital onset,11
mondo:disease_has_major_feature,disease has major feature,obo:HP_0006517,Alveolar proteinosis,11
obo:RO_0004029,disease has feature,obo:HP_0011107,Recurrent aphthous stomatitis,11
obo:RO_0004029,disease has feature,obo:HP_0030852,High pulse pressure,11
obo:RO_0004029,disease has feature,obo:MONDO_0001476,coloboma,11
obo:RO_0004029,disease has feature,obo:MONDO_0002082,endocrine gland neoplasm,11
obo:RO_0004029,disease has feature,obo:MONDO_0002508,gingivitis,11
obo:RO_0004029,disease has feature,obo:MONDO_0003664,hemolytic anemia,11
obo:RO_0004029,disease has feature,obo:MONDO_0004603,collagenopathy,11
obo:RO_0004029,disease has feature,obo:MONDO_0017255,panuveitis (disease),11
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_10335,Human alphaherpesvirus 3,11
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_1280,Staphylococcus aureus,11
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_5820,Plasmodium,11
obo:RO_0004028,realized in response to stimulus,obo:NCBITaxon_6236,Rhabditida,11
obo:RO_0004030,disease arises from structure,obo:UBERON_0001007,digestive system,11
obo:RO_0004027,disease has inflammation site,obo:UBERON_0001043,esophagus,11
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0001638,vein,11
obo:RO_0004026,disease has location,obo:UBERON_0001645,trigeminal nerve,11
obo:RO_0004026,disease has location,obo:UBERON_0001814,brachial nerve plexus,11
obo:RO_0004026,disease has location,obo:UBERON_0001831,parotid gland,11
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002108,small intestine,11
obo:RO_0004026,disease has location,obo:UBERON_0002165,endocardium,11
obo:RO_0004027,disease has inflammation site,obo:UBERON_0002349,myocardium,11
obo:RO_0004026,disease has location,obo:UBERON_0004913,hepatopancreatic ampulla,11
obo:RO_0004026,disease has location,obo:UBERON_0005989,atrioventricular septum,11
obo:RO_0004026,disease has location,obo:UBERON_0006877,vasculature of liver,11
obo:RO_0004026,disease has location,obo:UBERON_0016525,frontal lobe,11
obo:RO_0004020,disease has basis in dysfunction of,obo:UBERON_0035965,wall of blood vessel,11
obo:RO_0004026,disease has location,obo:UBERON_0036262,uterine ligament,11
